Experiments were conducted to test the hypothesis that estrogen treatment will regress a persistent dominant follicle developed during melengestrol acetate (MGA) treatment in the absence of a functional corpus luteum (CL) with normal fertility following development and ovulation of a newly recruited follicle. In Exp. 1, nonlactating beef cows ( n = 31) were administered . (MGAEV, n = 14) and the remainder were maintained on MGA ( n = 17). Ovaries were checked with ultrasound on d 8, 10, 12, and 14 of MGA treatment and every day until ovulation. A persistent dominant follicle developed in 90% of the MGA-treated cows by d 10 of treatment. Most of the MGA-treated cows ovulated the persistent dominant follicle ( n = 13/17), whereas EV treatment regressed the persistent dominant follicle ( n = 10/14) with the recruitment of a new follicle that ovulated ( n = 8/10). Diameter of the ovulatory follicle was larger ( P < .05) for the MGA (19.8 ± .6 mm) than for the control (15.1 ± .8 mm) and MGAEV (14.8 ± .7 mm) cows. In Exp. 2, nonlactating, multiparous beef cows ( n = 97) and yearling heifers ( n = 38) were equally allotted to either a control, MGA alone, or MGA + estradiol-17b (MGAE) group with the same dose of MGA as administered in Exp. 1. The 1st d of MGA feeding was the 1st d of treatment. On d 10 of treatment half the MGA-treated animals were injected i.m. with 5 mg of estradiol-17b. In controls, behavioral estrus was detected and animals were artificially inseminated ( A I ) for 5 d ( d 10 to 14 of experiment). All controls not exhibiting estrus by d 15 of experiment were injected with 25 mg of PGF 2a . The remaining controls and all MGA cows were observed for behavioral estrus and AI commenced for 7 d following withdrawal of MGA ( d 15 to 21 of experiment). More ( P < .05) controls (90.3%) than MGA (84.8%) or MGAE (63.6%) cows showed estrus within 7 d after MGA withdrawal. The percentage of animals conceiving to the synchronized estrus did not differ ( P > .05) among treatments. The data support our hypothesis that a persistent dominant follicle developed and can be regressed with exogenous estrogen treatment followed by the recruitment and ovulation of a new follicle after MGA withdrawal and fertility of that estrus does not seem to be significantly compromised.
Introduction
The effectiveness of an estrus synchronization system is measured by its ability to elicit a fertile, tightly synchronized estrous response in a majority of treated females (Odde, 1990) . The system must be cost-effective, require minimal labor, entail limited animal handling, and be user-friendly to a producer. Although numerous estrus synchronization systems have been evaluated (Odde, 1990; Patterson et al., 1992) , no one system meets all these requirements.
Melengestrol acetate ( MGA) is an inexpensive, orally active progestogen that suppresses estrus in feedlot heifers (Zimbelman and Smith, 1966; DeBois and Bierschwal, 1970) by inhibiting the ovulatory surge of LH (Zimbelman and Smith, 1966) . Fertility is reduced at the synchronized estrus following short (< 10 d; Beal et al., 1988; Chenault et al., 1990 ) and long-term (> 10 d; DeBois and Bierschwal, 1970; Zimbelman et al., 1970) MGA treatment compared to a spontaneous unsynchronized estrus (Zimbelman et al., 1970; Beal et al., 1988; Chenault et al., 1990) . Fertility at the subsequent estrus returns to normal (DeBois and Bierschwal, 1970; Zimbelman et al., 1970) . Brown et al. (1988) administered MGA for 14 d, allowed heifers to express estrus after MGA withdrawal, and injected prostaglandin F 2a (PGF 2a ) 16 d after the last day of MGA feeding. The MGA-PGF 2a system elicited a tightly synchronized and fertile estrus; however, this system lacks management flexibility by requiring a producer to plan a month before the breeding season with little opportunity to deviate from this schedule.
Follicular development in cattle occurs in a wavelike fashion (Rajakoski, 1960; Pierson and Ginther, 1984) , with two or three waves occurring during a normal estrous cycle (Savio et al., 1988; Sirois and Fortune, 1988) . The negative feedback effects of luteal progesterone decrease LH pulse frequency (Savio et al., 1993a) , resulting in turnover of the mid-cycle dominant follicle. When exogenous progestogen is administered to animals lacking a functional corpus luteum ( CL) (Sirois and Fortune, 1990; Savio et al., 1993b) there is continued growth and(or) maintenance of the dominant follicle. The persistent nature of the dominant follicle is associated with an increased LH pulse frequency due to lack of the negative feedback effects of luteal progesterone (Savio et al., 1993b; Kojima et al., 1995) . The persistent dominant follicle ovulates after progestogen withdrawal; however, fertility is significantly reduced compared to spontaneous ovulation in unsynchronized animals (Savio et al., 1993b) .
Estradiol valerate administration during early diestrus ( d 2 to 6 ) suppressed follicular growth and delayed emergence of the next follicular wave (Bo et al., 1993) , whereas estradiol valerate administered during late diestrus ( d 16) prevented ovulation of the preovulatory follicle (Engelhardt et al., 1989; Rjamahendran and Walton, 1990) . Therefore, we hypothesize that estradiol valerate treatment can regress and prevent the ovulation of a persistent dominant follicle. When estradiol valerate is used in combination with MGA, regression of the persistent dominant follicle should be followed by recruitment and ovulation of a new, more fertile follicle following MGA withdrawal.
Therefore, Exp. 1 was conducted to prove that a persistent dominant follicle develops in MGA-treated cows lacking a functional CL and exogenous estrogen administration can regress the persistent dominant follicle followed by recruitment and ovulation of a new follicle. Experiment 2 was conducted to evaluate the efficacy of MGA plus estradiol in synchronizing estrus and providing "acceptable" pregnancy rates in beef cattle.
Materials and Methods
Experiment 1. Nonlactating, cycling crossbred beef cows were allotted randomly to two groups. Group 1 served as controls ( n = 8 ) and estrus was synchronized with a single injection of 25 mg of PGF 2a (Lutalyse, Upjohn, Kalamazoo, MI) so that the subsequent estrus coincided with the 1st d ( d 0 of experiment) of MGA feeding in the remaining group of cows. The remaining cows ( n = 31) were administered MGA (Upjohn, Kalamazoo, MI) at a rate of .5 mg·cow -1 ·d -1 for 14 d ( d 0 to 14 of experiment) in a corn-based carrier that was mixed with ground corn ( 2 kg·cow -1 ·d -1 ) . All MGA-treated cows were fed as a group. All MGA cows were determined to have a palpable CL as determined by rectal palpation at the initiation of MGA treatment. The MGA-treated cows were injected i.m. with 25 mg of PGF 2a on d 6 and 8 of MGA treatment. On d 11 of MGA feeding approximately one-half ( n = 13) were injected i.m. with 5 mg of estradiol valerate ( MGAEV; Sigma Chemical Co., St. Louis, MO).
Ovarian ultrasonography was performed using a real-time, B-mode scanner (Aloka 500, Corometrics Medical Systems, Wallingford, CT) equipped with a 7.5-Mhz linear transducer. Ovaries of control cows were examined starting on d 8, 10, 12, and 14 of their estrous cycle and then every day until ovulation. Ovaries of MGA and MGAEV cows were examined on d 8, 10, 12, and 14 of MGA feeding and then every day until ovulation. Ultrasound scans were recorded on a VCR tape and played back at a later date to evaluate follicular growth patterns. Ovarian maps were drawn and the relative position of follicles > 5 mm were recorded. In control cows, a dominant follicle was identified by the presence of a large follicle (> 10 mm) with no new follicles > 5 mm being detected during its dominance (Ginther et al., 1989) . A follicle was deemed persistent if it continued to grow and(or) became arrested and did not decrease in diameter through the last day of MGA feeding. An ovulatory follicle was identified as acute disappearance of the largest follicle on the ovaries as determined by ultrasonography. The diameter of follicle the day prior to its acute disappearance was used as the diameter of the ovulatory follicle. Blood samples were collected by jugular venipuncture from all cows concurrent with ultrasonic examinations to determine immunoreactive estradiol-17b concentrations in plasma. Progesterone concentrations in plasma were determined on d 5, 10, and 15 post-ovulation to access luteal function. Blood samples were placed on ice, centrifuged within 1 h, and plasma was decanted and stored at −20°C until hormone analyses could be performed. Tailheads of MGA and MGAEV cows were chalked on d 0 of MGA treatment and all cows were observed for estrus at 0700 during MGA treatment and twice daily (0700 and 1700) after withdrawal of MGA until estrus was observed. Estradiol-17b was quantified with RIA (see Appendix). Plasma concentrations of progesterone were quantified by a direct, solid-phase RIA kit according to the basic procedure provided by the manufacturer (Diagnostic Products, Los Angeles, CA). Assay validation was reported previously (Reimers et al., 1991) . Intra-and interassay CV for bovine plasma pools containing 2.5 and 10.4 ng/mL progesterone were 10.1 and 12.3%, and 5.5 and 6.2%, respectively. Sensitivity of the assay averaged 30 pg/mL ( 3 pg/tube).
Interval to estrus (interval to behavioral estrus in hours after MGA withdrawal) and estrous response (number in estrus within 7 d after treatment divided by number in group) were analyzed with ANOVA in MGA and MGAEV cows and ovulation rate (number ovulating divided by the number treated) and size of the ovulatory follicle were analyzed with ANOVA for control, MGA, and MGAEV cows. Follicle size during MGA treatment and progesterone and estrogen concentrations were analyzed as split-plot designs (Gill and Hafs, 1971 ) using PROC GLM procedures of SAS (1988) . Main effect was treatment and cow within treatment was the error term for the main plot. Day and treatment × day were the subplot with the residual as the error term. Immunoreactive estradiol17b concentrations were evaluated on d 8, 10, 12, and 14 of MGA feeding and retrospectively for the 3 d before ovulation. Progesterone concentrations were analyzed for d 5, 10, and 15 postovulation. Mean separation tests were done using PDIFF in SAS (1988) with cow within treatment as the error term. Only animals with progesterone concentrations greater than 1 ng/mL at all three bleedings were included in the analyses. Four MGA and three MGAEV animals were not bled after ovulation and were not included in the progesterone analyses.
Experiment 2. This experiment was conducted to determine the efficacy of the MGAEV synchronization system (Exp. 1 ) in a field situation and to compare the fertility of the MGAEV-synchronized estrus with the estrous response and fertility in cattle synchronized with either MGA alone or after a PGF 2a injection. Progesterone concentrations at initiation of MGA treatment were also evaluated to determine whether plasma progesterone concentrations influenced fertility at the MGA-synchronized estrus. In Exp. 1, the behavioral estrus following EV injection was very intense and of extended duration compared with that of MGA-treated cows. Englehardt et al.
(1989) also observed persistent behavioral estruses in ovariectomized cows 1 to 5 d after EV injection. As a result, estradiol-17b was used in Exp. 2 instead of EV, because previous reports (Rajamahendran and Manikkam, 1994) showed that exogenous estradiol17b could regress late luteal phase dominant follicles maintained under norgestomet. Furthermore, estradiol-17b was administered on d 10 instead of d 11 (Exp. 1 ) to allow adequate time for regression of the persistent dominant follicle. Yearling heifers ( n = 38) and multiparous ( n = 97) nonlactating crossbred beef cows were randomly assigned by age and body condition score (Wagner et al., 1988) to three treatment groups ( n = 45/group). Cows in groups 2 and 3 were administered MGA at a rate of .5 mg·cow -1 ·d -1 for 14 d. On d 10, half the MGA animals were injected i.m. with 5 mg of estradiol-17b ( MGAE; Sigma Chemical). Blood samples were taken by jugular venipuncture from MGA and MGAE cows on d 0, 5, and 10 of MGA feeding. Blood samples were placed on ice, centrifuged within 1 h, and plasma was decanted and stored at −20°C until hormone analyses could be performed. Progesterone was quantified with RIA (Reimers et al., 1991) . The 1st d of MGA feeding in MGA and MGAE cows was considered as d 0 of the experiment. Controls were kept in drylot and fed native grass hay for the duration of treatment and estrus behavior was observed at 0700 and 1700 for 5 d ( d 10 to 14 of experiment) with artificial insemination ( AI) occurring 12 h after first observed standing behavioral estrus. On d 6 of estrus detection ( d 15 of experiment) all controls that had not exhibited behavioral estrus were injected i.m. with 25 mg of PGF 2a with continued estrus detection and AI for 7 d ( d 15 to 21 of experiment). All MGA-treated cows grazed a single old world bluestem pasture. The MGA was administered in a 20% protein range cube fed at a rate of 2.2 kg·cow -1 ·d -1 . Tail heads of all cows and heifers were chalked on d 0 of the experiment to aid in the detection of estrus during MGA feeding. The day after MGA withdrawal ( d 15 of experiment), the MGA and MGAE cows were combined in drylot with control cows for a 7-d breeding period ( d 15 to 21 of experiment). Detection of estrus and AI continued as described above. A single experienced AI technician bred all animals. Frozen semen from a single collection from each of two sires was used with one sire assigned to heifers and the other sire assigned to multiparous cows. On d 22 of the experiment, all animals were placed in pastures with cleanup bulls for the remainder of the 60-d breeding season.
Treatment effects were analyzed using ANOVA. Independent variables tested were treatment, age (yearling heifer vs multiparous cows), and treatment × age. Dependent variables tested were 7-d estrus rate (number in estrus within 7 d after treatment divided by number in group), interval to estrus (interval to standing estrus in hours after MGA withdrawal for MGA-and MGAE-treated animals and after PGF 2a injection for controls), synchronized conception rate (number pregnant within 7 d after treatment divided by number inseminated), synchronized pregnancy rate (number pregnant within 7 d after treatment divide by total in group), and 28-d pregnancy rate (number pregnant within 28 d after treatment divided by total in group). Means were separated using PDIFF of SAS (1988) . Three controls exhibited behavioral estrus and were artificially inseminated during the 5 d before PGF 2a injection but were not included in the final analyses of treatment effects. There was a significant treatment × age effect on interval to estrus and 28-d pregnancy rate; therefore, heifer and cow data were analyzed separately for all variables.
Results
Experiment 1. More ( P < .05) MGAEV (100%) cows exhibited estrus than MGA cows (76.5%) whereas interval from MGA withdrawal to behavioral estrus was not different ( P > .05) between MGA (95.1 ± 1.8 h ) and MGAEV (100.4 ± 11.3 h ) cows. Ovulation rate did not differ ( P > .05) between MGA (94.1%) and MGAEV (78.6%) cows, and all control cows ovulated. Diameter of the ovulatory follicle was larger ( P < .05) for the MGA (19.8 ± .6 mm) than for the control (15.1 ± .8 mm) and MGAEV (14.8 ± .7 mm) cows. A persistent dominant follicle was observed in 84% of the MGA (14/17) and in 100% of the MGAEV (14/14) cows. Of the MGA cows ( n = 17) that ovulated, 13 cows ovulated a persistent dominant follicle, and 3 cows exhibited dominant follicle turnover during MGA treatment with ovulation of a newly recruited follicle after MGA withdrawal. The remaining MGA cow developed a cystic follicle that did not ovulate during the duration of the experiment. Of the MGAEV cows ( n = 14), EV treatment regressed 10/14 persistent dominant follicles with recruitment of a new follicle that ovulated ( n = 8 ) or failed to ovulate ( n = 2). Of the four remaining MGAEV cows, two cows ovulated their persistent dominant follicles, one cow developed a nonovulatory cystic follicle, and the remaining cow ovulated a follicle that was recruited and developed into a dominant follicle before EV administration.
Typical follicular growth patterns for each respective treatment are represented in Figure 1 . Control cows exhibited either two-or three-wave follicular growth patterns; a 3-wave follicular growth pattern is depicted in Figure 1a . The dominant follicle of MGA cows in the absence of luteal-phase progesterone concentrations became persistent on approximately d 10 to 12 of MGA treatment (Figure 1b) . There was no subordinate follicle recruitment during the presence of the persistent dominant follicle. After EV administration ( d 11 of MGA treatment; Figure 1c ), the diameter of the persistent dominant follicle remained arrested for several days and eventually regressed. Approximately 1 to 2 d after EV injection, subordinate follicles began to develop with the selection and subsequent ovulation of a new dominant follicle several days after MGA withdrawal.
There was a treatment × day effect ( P < .01) on diameter of the persistent dominant follicle of MGA and MGAEV cows and for the first-and second-wave dominant follicles of untreated controls. First-wave dominant follicles of control cows reached maximal diameter (12.5 ± .5 mm) on d 10 of the estrous cycle and began to regress by d 12 and 14 (11.5 ± .5 and 9.6 ± .6 mm, respectively), whereas the second-wave dominant follicle began to appear on approximately d 8 (6.2 ± 1.4 mm) with a continued increase in diameter on d 10, 12, and 14 of the estrous cycle. Diameter of the persistent dominant follicle increased from 12.8 ± .6 mm to 15.7 ± .5 mm in MGA cows and from 13.0 ± .5 mm to 15.9 ± .5 mm in MGAEV cows on d 8 to d 10 of MGA treatment. Size of the persistent dominant follicle increased ( P < .05) from d 12 (17.6 ± .6 mm) to d 14 (18.7 ± .5 mm) in MGA cows, whereas growth of the persistent dominant follicle became arrested 1 d after EV administration in MGAEV cows and began to regress (15.7 ± .6 mm) by d 14 of MGA feeding.
Immunoreactive concentrations of plasma estradiol17b did not differ ( P > .05) between MGA and MGAEV cows on d 8 of MGA feeding, but their concentrations exceeded those of controls (Figure 2a) . Concentrations of estradiol-17b were greater ( P < .05) on d 10 in MGA cows than in controls and MGAEV cows. On d 12 and 14 of MGA feeding, the control cows had lower ( P < .05) estradiol-17b concentrations than MGA and MGAEV cows. Plasma concentration of immunoreactive estradiol-17b were greater in MGAEV than in MGA cows after EV injection on d 11 of MGA administration. When immunoreactive estradiol-17b concentrations were arranged relative to days before ovulation (Figure 2b) , control cows had lower ( P < .05) estrogen concentrations for the 4 d before ovulation than MGA and MGAEV cows whereas MGAEV cows had greater ( P < .05) estradiol-17b concentrations then MGA cows in the preovulatory period.
Progesterone concentrations on d 5, 10, and 15 after ovulation were determined to evaluate luteal function in response to the MGA-synchronized estrus (Table  1) . Data only include animals that expressed normal luteal function as assessed by progesterone concentrations greater than 1.0 ng/mL for all 3 d. Several MGA ( n = 4/13) and MGAEV ( n = 3/8) cows had short luteal phases as indicated by progesterone concentrations less than 1.0 ng/mL on d 10 and(or) 15 after ovulation. Control and MGA cows had greater ( P < .05) progesterone concentrations for all 3 d than MGAEV cows, with the exception of d 10, when progesterone concentrations for control and MGAEV cows did not differ ( P > .05).
Experiment 2. A treatment × age effect on interval to estrus and 28-d pregnancy rates was detected ( P < .05); therefore, data in Table 2 are presented separately for nonlactating multiparous cows and yearling heifers. Interval to estrus was not different ( P < .05) within an age class and among treatments. More ( P < .05) control cows exhibited estrus after PGF 2a injection than MGA and MGAE cows, and more ( P < .05) MGA cows exhibited estrus than MGAE cows. Twelve cows in the MGAE group exhibited estrus shortly after estradiol-17b treatment while being administered MGA and did not exhibit estrus during the 7 d after MGA withdrawal. Estrous response of yearling heifers did not differ ( P > .05) among treatments.
Synchronized conception rate did not differ ( P < .05) between treatments within cow and heifer treatment groups. More ( P < .05) control cows became pregnant in the first 7 d of the breeding season (synchronized pregnancy rate) than MGAE cows, but no difference was observed between controls and MGA cows. The number of MGA and MGAE cows pregnant in the first 7 d of the breeding season did not differ ( P > .05). Synchronized pregnancy rate did not differ ( P > .05) among treatments for yearling heifers. Twentyeight-day pregnancy rates did not differ ( P > .05) across treatments within cows and heifers. Of the 12 MGAE cows that showed estrus while still being administered MGA, 10 of these cows became pregnant approximately 20 d after the estradiol-17b injection. Plasma progesterone concentrations were evaluated on d 0, 5, and 10 of MGA treatment in MGA cows and heifers. Animals that became pregnant during the 7-d synchronized estrus following MGA withdrawal were divided into two groups: those with progesterone concentrations > 1.5 ng/mL on d 1 of MGA feeding and those with progesterone concentrations < 1.5 ng/mL. More (63.6 %; P < .1) cows and heifers with progesterone concentrations > 1.5 ng/mL on d 1 of MGA feeding became pregnant during the synchronized estrus than cattle with progesterone concentrations < 1.5 ng/mL (41.1%).
Discussion
Results from Exp. 1 indicate that a persistent dominant follicle developed during MGA treatment in the absence of a functional CL. The persistent dominant follicle ovulated after MGA withdrawal and obtained a greater diameter than second-or thirdwave ovulatory follicles in unsynchronized controls. Results of the present experiment agree with previous reports of persistent dominant follicle development in the absence of a functional CL and under low progestogen ovulatory regulation with either MGA (Anderson and Day, 1994; Custer et al., 1994) , norgestomet implant (Savio et al., 1993a; Taylor et al., 1993; Taylor and Rajamahendran, 1994) , or a controlled internal release device (Sirois and Fortune, 1990; Savio et al., 1993b) .
The mechanism by which the dominant follicle becomes persistent under low circulating progesterone concentrations (< 2 ng/mL) is associated with an altered LH secretory pattern. The frequency of LH pulses increases when the CL is removed and an exogenous progestogen is administered (Roberson et al., 1989; Sirois and Fortune, 1990; Savio et al., 1993a) . The increased pulse frequency of LH sustains follicular growth (See Lucy et al., 1992) similar to pre-ovulatory LH secretion (Rahe et al., 1980; Walters et al., 1984) . The persistent dominant follicle can be regressed (Sirois and Fortune, 1990; Savio et al., 1993a,b) either when the exogenous source of progestogen is removed or additional progestogens (Sirois and Fortune, 1990; Savio et al., 1993a,b; Taylor and Rajamahendran, 1994) are administered to mimic luteal phase progesterone concentrations and to provide the necessary negative feedback effect of progesterone to decrease LH pulse frequency (Savio et al., 1990 (Savio et al., , 1993b . However, LH pulse frequency cannot be decreased when MGA is administered at levels greater than those used for estrus synchronization (Kojima et al., 1995) . Therefore, administering increased amounts of MGA during the middle of an extended MGA treatment will not decrease the LH pulse frequency and the persistent dominant follicle will likely not regress. This unequivocally limits the opportunity to use MGA alone as an estrus synchronization agent.
The continued growth and persistence of the dominant follicle had a significant effect on follicular dynamics in MGA-treated cows compared to controls. In the presence of the persistent dominant follicle there was an immediate atresia of follicles smaller than the dominant follicle ( 5 to 9 mm) and virtually no recruitment of subordinate follicles (< 5 mm). Control cows had waves of follicular growth similar to those previously described (Pierson and Ginther, 1984; Savio et al., 1988 Savio et al., , 1990 . Altered follicular development in the presence of a persistent dominant follicle and low progesterone environment has been previously reported (Sirois and Fortune 1990; Savio et al., 1993a,b; Taylor and Rajamahendran, 1994) . Local factors secreted by the persistent dominant follicle may directly and(or) indirectly inhibit subordinate follicle development either locally and(or) systemically (Lucy et al., 1992; Findlay, 1994) . However, the mechanism by which dominant and persistent dominant follicles suppress subordinate follicle growth has yet to be determined.
Estradiol valerate administration initiated the regression of the persistent dominant follicle and did not lead to ovulation of the persistent dominant follicle. Although LH secretory profiles were not determined in the present study, exogenous estrogen treatments do not induce a preovulatory-like surge of LH in the progestogen-treated cows (Bolt et al., 1990; Bo et al., 1994) . In all probability, estradiol valerate has a negative effect on the hypothalamic-pituitary axis (Englehardt et al., 1989) by decreasing the number of LH pulses (Rajamahendran and Manikkam, 1994) resulting in atresia (Rajamahendran and Manikkam, 1994) of the persistent dominant follicle.
Luteal function was assessed by determination of plasma progesterone concentrations on d 0, 10, and 15 after ovulation in Exp. 1. Cows that ovulated a newly recruited follicle after treatment with estradiol valerate had lower circulating progesterone concentrations than MGA-treated cows that ovulated a persistent dominant follicle, agreeing with reports of Wehrman et al. (1993) . Wehrman and coworkers (1993) maintained cows on either a low or a high progestogen regimen for 10 d to mimic two different levels of CL function. After removal of the exogenous progestogen source, cows maintained with low progestogen stimulation had greater concentrations of circulating progesterone than cattle maintained on a highprogestogen treatment. Differences in follicular turnover and subsequent progesterone production by the CL were attributed to prior progestogen treatments. When the data were examined independent of treatment, there was no difference in concentrations of progesterone between animals that conceived and those that failed to conceive. These data support the theory that luteal insufficiency does not lead to decreased pregnancy rates at the estrus following progestogen withdrawal. However, it should be noted that, the incidence of several short luteal phases was observed in a small percentage of MGA-treated cows in the present study. Short-lived luteal structures may be one of the causes for lowered fertility in MGAtreated cows.
The fertility of the cows on the MGAE treatment was not significantly compromised compared to controls. This agrees with previous reports in which the persistent dominant follicle was regressed during progestogen treatment and a new follicle was ovulated at progestogen withdrawal (Savio et al., 1993b; Anderson and Day, 1994) . Typically, the fertility of an ovulated persistent dominant follicle after long-term progestogen treatment is decreased compared to a normal ovulation. The exact causes for the decreased fertility seem to be both uterine and ovarian dysfunctions. Low-level progestogen treatment in the absence of a functional CL can disrupt follicular development (Lamond et al., 1971; Savio et al., 1993a) , affect ova transport (Reed and Rich, 1972) , reduce sperm transport (Lauderdale and Ericsson, 1970) , alter cleavage rates (Wishart and Young, 1974; Ahmad et al., 1995) , disrupt uterine epithelium morphology (Wordinger et al., 1971 (Wordinger et al., , 1972 , and significantly alter the circulating hormonal milieu (Henricks et al., 1970; Randel et al., 1972; Chow et al., 1982) . The increased concentrations of circulating estrogen associated with the persistent dominant follicle are thought to be responsible for many of these dysfunctions that may result in poor fertility at the estrus following progestogen removal. Nevertheless, this does not explain why fertilization and further conceptus development is not compromised in a newly recruited and ovulated follicle (Savio et al., 1993b; Anderson and Day, 1994) even though the uterus and ovaries of these animals are exposed to the same elevated estrogen concentrations as those of animals with a persistent dominant follicle. These data suggest that the proper communication necessary for maternal recognition of pregnancy between the embryo and uterus (Geisert et al., 1994) is not compromised in progestogen-treated cows that ovulate a newly recruited follicle after regression of the persistent dominant follicle. However, recent data indicate that oocytes from persistent dominant follicles can be fertilized but their subsequent development is compromised (Ahmad et al., 1995) . These data suggest that increased circulating estrogens may have more influence on the developmental capacity of follicles close to ovulation but not subordinate follicles that can be recruited and eventually ovulated.
Fertility of animals treated with MGA alone was greater than expected. The average numbers of animals becoming pregnant to the estrus after MGA withdrawal is approximately 30% in heifers (De Bois and Bierschwal, 1970; Zimbelman et al., 1970) . In retrospect, MGA cows with progesterone concentrations greater than 1.5 ng/mL on the 1st d of MGA feeding had 30% greater conception rates than those with progesterone concentrations less than 1.5 ng/mL.
Although it was not determined in Exp. 2, it seems that if endogenous progesterone concentrations are greater than 1.5 ng/mL on the initial day of a longterm MGA treatment, follicle turnover probably occurs during MGA treatment, resulting in ovulation of viable oocytes after MGA withdrawal instead of development and ovulation of a persistent dominant follicle with low viability. These data suggest that elimination of the dominant follicle before it becomes persistent during a long-term progestogen treatment may be a better method of synchronizing estrus than dealing with the persistent dominant follicle and its lowered fertility.
The number of MGAE animals showing behavioral estrus was significantly less than controls and MGAtreated animals. The decreased number of MGAE cows exhibiting estrus is a result of approximately 12 cows exhibiting estrus shortly after estradiol-17b administration but while still being administered MGA. These animals did not show behavioral estrus during the 7-d AI period after MGA withdrawal but 10 of the 12 cows were later determined to have become pregnant to the cleanup bull approximately 20 d after they exhibited estrus during the MGA treatment. In all probability, these cows did not consume adequate amounts of the MGA supplement in the field trial and broke through the estrus suppression effect of MGA and ovulated. Therefore, it is imperative that animals not miss an MGA feeding during treatment to receive maximal estrus expression after MGA withdrawal.
The true effectiveness of an estrus synchronization system is measured by the number of animals that become pregnant during the synchronized estrus of the total in the group, also known as the synchronized pregnancy rate. The synchronized pregnancy rate for controls was relatively high and can be attributed to the large number of animals cycling at the initiation of treatment. Although the number of MGA-and MGAEtreated animals that became pregnant in the first 7 d of the breeding season was low it was within the range for animals synchronized with Syncro-Mate B and(or) several progestogen + PGF 2a combinations (Odde, 1990; Yelich et al., 1994) . There seemed to be no residual effects of the estradiol-17b; 28-d and breeding season pregnancy rates were not compromised compared to those of the controls.
Melengestrol acetate used in combination with an exogenous estrogen could provide the cattle producer an estrus synchronization system with several advantages compared to other synchronization systems. Because MGA is orally active, animals do not have to be handled through a working facility to administer it, unlike implants, controlled internal drug-releasers, and progesterone-releasing intravaginal devices. Furthermore, animals need to be handled only twice, once to inject with estrogen and the other for AI, or once if natural service is used. Most progestogen estrus synchronization systems require handling the animals two to three times. The start of the breeding season can be planned 14 d in advance instead of 32 d, as needed with the traditional MGA-PGF 2a system (Brown et al., 1988) . However, further research must be conducted to evaluate the type, amount of sex steroid used, and the timing of administration along with the resulting estrus and conception rates. An increased number of animals pregnant early in the breeding season can benefit the producer by shortened calving intervals, decreased labor requirements, and a more uniform calf crop at weaning.
Implications
Development of an estrus synchronization protocol that requires minimal labor, management, and handling of livestock would greatly enhance the utilization of artificial insemination in beef cattle production. Using melengestrol acetate in combination with exogenous estrogen to synchronize estrus has the opportunity to be a viable estrus synchronization system. Furthermore, the persistent dominant follicle can be used as an experimental model to examine secretory factors that initiate follicle atresia and suppress recruitment of subordinate follicles.
